People · Operator
Named in public records as an officer, director or promoter · active 2010–2011 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bioventrix Inc | — | Other | Series B | $191.3M | $20.8M | 2010 |
Kevin E. Van Bladel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin E. Van Bladel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BIHUA CHEN | 1 | 14 |
| Kenneth Miller | 1 | 8 |
| Michael Taglich | 1 | 7 |
| Ken Miller | 1 | 5 |
| Arthur Bertolero | 1 | 5 |
| Steven Healy | 1 | 3 |
| WILLIAM ABBOTT | 1 | 3 |
| George Fazio | 1 | 3 |
| Robert Taglich | 1 | 3 |
| William Abraham | 1 | 2 |
| DAVID RICHMOND | 1 | 2 |
| JAMES DILLON | 1 | 2 |
| Christopher Wolff | 1 | 2 |
| Raymond Cohen | 1 | 2 |
| Rinda Sama | 1 | 2 |
| ANDREW COATS | 1 | 2 |
| Kevin Van Bladel | 1 | 1 |
| Lon Annest | 1 | 1 |
| Kevin Von Bladel | 1 | 1 |
| Warren Pinckert | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.